Pnc Financial Services Group, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 171 shares of MIRM stock, worth $6,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171
Previous 223
23.32%
Holding current value
$6,686
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MIRM
# of Institutions
212Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$257 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$179 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$127 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$109 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$102 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.44B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...